These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 26860839)

  • 41. Management of cardiac implantable electronic device follow-up in COVID-19 pandemic: Lessons learned during Italian lockdown.
    Piro A; Magnocavallo M; Della Rocca DG; Neccia M; Manzi G; Mariani MV; Straito M; Bernardini A; Severino P; Iannucci G; Giunta G; Chimenti C; Natale A; Fedele F; Lavalle C
    J Cardiovasc Electrophysiol; 2020 Nov; 31(11):2814-2823. PubMed ID: 32954600
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
    Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
    Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
    Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
    Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibiotic Prophylaxis and Treatment in Early Cardiac Implantable Electronic Devices Infection.
    Alshoubaki O; Al Darabaa Z; Odat O; Qubbaj A; Alhyari R; Alshare S; Ghanma I
    Med Arch; 2021 Feb; 75(1):56-60. PubMed ID: 34012201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implantable defibrillators improve survival in patients with mildly symptomatic heart failure receiving cardiac resynchronization therapy: analysis of the long-term follow-up of remodeling in systolic left ventricular dysfunction (REVERSE).
    Gold MR; Daubert JC; Abraham WT; Hassager C; Dinerman JL; Hudnall JH; Cerkvenik J; Linde C
    Circ Arrhythm Electrophysiol; 2013 Dec; 6(6):1163-8. PubMed ID: 24125796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cardiac resynchronisation therapy: pacemaker versus internal cardioverter-defibrillator in patients with impaired left ventricular function.
    Looi KL; Gajendragadkar PR; Khan FZ; Elsik M; Begley DA; Fynn SP; Grace AA; Heck PM; Virdee M; Agarwal S
    Heart; 2014 May; 100(10):794-9. PubMed ID: 24691411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term outcome after ICD and CRT implantation and influence of remote device follow-up: the ALTITUDE survival study.
    Saxon LA; Hayes DL; Gilliam FR; Heidenreich PA; Day J; Seth M; Meyer TE; Jones PW; Boehmer JP
    Circulation; 2010 Dec; 122(23):2359-67. PubMed ID: 21098452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2015].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Botto GL; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2017 Jan; 18(1):67-79. PubMed ID: 28287212
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE).
    García-Fernández FJ; Osca Asensi J; Romero R; Fernández Lozano I; Larrazabal JM; Martínez Ferrer J; Ortiz R; Pombo M; Tornés FJ; Moradi Kolbolandi M
    Eur Heart J; 2019 Jun; 40(23):1837-1846. PubMed ID: 30793735
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Remote monitoring for active cardiovascular implantable electronic devices: a European survey.
    Halimi F; Cantù F;
    Europace; 2010 Dec; 12(12):1778-80. PubMed ID: 21097482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Remote Monitoring of Implantable Cardioverter-Defibrillators: A Systematic Review and Meta-Analysis of Clinical Outcomes.
    Parthiban N; Esterman A; Mahajan R; Twomey DJ; Pathak RK; Lau DH; Roberts-Thomson KC; Young GD; Sanders P; Ganesan AN
    J Am Coll Cardiol; 2015 Jun; 65(24):2591-2600. PubMed ID: 25983009
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Implantation success and infection in cardiovascular implantable electronic device procedures utilizing an antibacterial envelope.
    Bloom HL; Constantin L; Dan D; De Lurgio DB; El-Chami M; Ganz LI; Gleed KJ; Hackett FK; Kanuru NK; Lerner DJ; Rasekh A; Simons GR; Sogade FO; Sohail MR;
    Pacing Clin Electrophysiol; 2011 Feb; 34(2):133-42. PubMed ID: 20942819
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: An analysis from the EFFECT study.
    D'Onofrio A; Stabile G; Capucci A; Amellone C; De Simone A; Leoni L; Morani G; Bianchi V; Campari M; Valsecchi S; Buja G;
    J Telemed Telecare; 2016 Oct; 22(7):383-90. PubMed ID: 26703214
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Economic analysis of remote monitoring of cardiac implantable electronic devices: Results of the Health Economics Evaluation Registry for Remote Follow-up (TARIFF) study.
    Ricci RP; Vicentini A; D'Onofrio A; Sagone A; Rovaris G; Padeletti L; Morichelli L; Fusco A; De Vivo S; Lombardi L; Denaro A; Pollastrelli A; Colangelo I; Santini M
    Heart Rhythm; 2017 Jan; 14(1):50-57. PubMed ID: 27614025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker.
    Schuchert A; Muto C; Maounis T; Frank R; Boulogne E; Polauck A; Padeletti L;
    Europace; 2013 Jan; 15(1):71-6. PubMed ID: 22927665
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative effectiveness of cardiac resynchronization therapy with an implantable cardioverter-defibrillator versus defibrillator therapy alone: a cohort study.
    Masoudi FA; Mi X; Curtis LH; Peterson PN; Curtis JP; Fonarow GC; Hammill SC; Heidenreich PA; Al-Khatib SM; Piccini JP; Qualls LG; Hernandez AF
    Ann Intern Med; 2014 May; 160(9):603-11. PubMed ID: 24798523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiac resynchronization therapy and implantable cardiac defibrillators in left ventricular systolic dysfunction.
    McAlister FA; Ezekowitz J; Dryden DM; Hooton N; Vandermeer B; Friesen C; Spooner C; Rowe BH
    Evid Rep Technol Assess (Full Rep); 2007 Jun; (152):1-199. PubMed ID: 17764218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technician-Supported Remote Interrogation of CIEDs: Initial Use in US Emergency Departments and Perioperative Areas.
    Ahmed I; Patel AS; Balgaard TJ; Rosenfeld LE
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):275-81. PubMed ID: 26647906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.